Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
Department of Emergency Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Pain Med. 2021 Jul 25;22(7):1570-1582. doi: 10.1093/pm/pnaa412.
To synthesize the literature on the proportion of health care providers who access and use prescription monitoring program data in their practice, as well as associated barriers to the use of such data.
We performed a systematic review using a standard systematic review method with meta-analysis and qualitative meta-summary. We included full-published peer-reviewed reports of study data, as well as theses and dissertations.
We identified relevant quantitative and qualitative studies. We synthesized outcomes related to prescription monitoring program data use (i.e., ever used, frequency of use). We pooled the proportion of health care providers who had ever used prescription monitoring program data by using random effects models, and we used meta-summary methodology to identify prescription monitoring program use barriers.
Fifty-three studies were included in our review, all from the United States. Of these, 46 reported on prescription monitoring program use and 32 reported on barriers. The pooled proportion of health care providers who had ever used prescription monitoring program data was 0.57 (95% confidence interval: 0.48-0.66). Common barriers to prescription monitoring program data use included time constraints and administrative burdens, low perceived value of prescription monitoring program data, and problems with prescription monitoring program system usability.
Our study found that health care providers underutilize prescription monitoring program data and that many barriers exist to prescription monitoring program data use.
综合评估医疗保健提供者在实践中获取和使用处方监测计划数据的比例，以及使用此类数据的相关障碍。
我们采用标准的系统评价方法进行了系统评价，包括荟萃分析和定性荟萃分析。我们纳入了完整的同行评审研究数据报告，以及论文和学位论文。
我们确定了相关的定量和定性研究。我们综合了与处方监测计划数据使用相关的结果（即，是否使用过、使用频率）。我们使用随机效应模型汇总了曾经使用过处方监测计划数据的医疗保健提供者的比例，并使用荟萃分析方法确定了处方监测计划使用障碍。
我们的综述共纳入了 53 项研究，均来自美国。其中，46 项报告了处方监测计划的使用情况，32 项报告了障碍情况。曾经使用过处方监测计划数据的医疗保健提供者的比例为 0.57（95%置信区间：0.48-0.66）。处方监测计划数据使用的常见障碍包括时间限制和行政负担、处方监测计划数据的低感知价值以及处方监测计划系统可用性问题。
我们的研究发现，医疗保健提供者对处方监测计划数据的利用不足，并且存在许多使用处方监测计划数据的障碍。
